AAD Supports FDA Plan to Approve New Sunscreen Ingredient
WASHINGTON, D.C., December 11, 2025 — The American Academy of Dermatology Association (AAD) issued a formal statement supporting the...
.Gov for New Therapy
Red Squirrel Conservation Efforts Gain Boost From New Field Insights
SCOTLAND, December 8, 2025 — A Scottish wildlife photographer’s work capturing the behaviors and habitat challenges of the native...
FDA Advances Tradipitant Review for Motion Sickness Relief
Washington, D.C., November 28, 2025 In a significant regulatory development, Vanda Pharmaceuticals Inc. has announced major progress on tradipitant,...
ASTHO Board Reaffirms Vaccine Support to Strengthen Public Health
Arlington, VA — September 5, 2025 — The Board of Directors of the Association of State and Territorial Health...
FDA Approves Updated 2025–2026 COVID-19 Vaccines from Pfizer, Moderna, and Novavax
The FDA has approved updated COVID-19 vaccines from Pfizer/BioNTech, Moderna, and Novavax for the 2025-2026 season, targeting high-risk groups....
FDA Ends Broad Emergency Authorization, Approves Updated COVID-19 Vaccines
The FDA approved updated COVID-19 vaccines from Pfizer/BioNTech, Moderna, and Novavax while ending broad Emergency Use Authorization. Eligibility is...
FDA Launches PreCheck Program to Strengthen U.S. Drug Manufacturing
August 7, 2025 – The U.S. Food and Drug Administration (FDA) has announced the launch of FDA PreCheck, a...